4DMedical receives TGA approval for XV LVAS

• The Australian Therapeutic Goods Administration (TGA) has approved 4DMedical’s XV Lung Ventilation Analysis Software (XV LVAS) for inclusion in the Australian Register of Therapeutic Goods (ARTG) • XV LVAS utilises the Company’s proprietary XV Technology™, which converts sequences of X-ray images into four-dimensional quantitative data by using patented mathematical models and algorithms • XV LV